Serobid Rotacaps 50mcg
Available Dosages
| SKU | 917 |
|---|---|
| Generic For | Serevent |
| Strength | 50 mcg |
| Active Ingredient | Salmeterol |
Out Of Stock
Serobid Rotacaps 50mcg (Salmeterol) – Affordable Serevent Alternative
Serobid Rotacaps 50mcg
Serobid Rotacaps 50mcg are capsules of powdered medication which are meant to be placed in a Rotahaler. It would be best if you inhaled it to get the medication from the Rotacap. When used correctly, the medicine directly reaches to the small airways in the lungs. These Rotacaps contain salmeterol as the active ingredient, which is an appropriate treatment for patients with asthma. Doctors prescribe Salmeterol Rotacaps for the treatment of asthma as concomitant treatment with an inhaled corticosteroid. The medicine is effective for patients with nocturnal asthma and exercise-induced asthma. Serobid can also be used for the maintenance treatment bronchospasm associated with chronic obstructive pulmonary disease or COPD. The asthma medication causes relaxation of muscles and opens the air passages in the lungs.
Before using Rotacaps Rotacaps, inform your doctor about all the medications that you have been using or used in the past. These may include vitamins or herbal supplements. Also, let your doctor know about allergies, pre-existing medical conditions, and current health status, including pregnancy or upcoming surgery). Certain health issues may make you more susceptible to the side effects of the drug. Hence, one should take medicine as directed by the doctor. The correct dosage is based on the condition of the patient. Inform your doctor if your condition worsens or persist for a longer duration. Do not inhale a double dose of this asthma medication. If you use other prescription medications at the same time, the effects of serobid may reduce. Co-administration of certain drugs may increase your risk for side effects or cause your drug not to work properly. Tell your doctor as early as possible, so that the doctor can help manage drug interaction. Serobid may interact with brimonidine, amoxicillin, carteolol, darunavir, amprenavir, clarithromycin, Boceprevir, Fortovase, and indinavir.
Do not swallow the capsules. The medicine in your Serobid Rotacap is meant for inhalation only. Rotahaler is a device which opens the capsules in the powdered form. Make sure you follow the usage instructions carefully and use the Rotahaler properly. You must visit your doctor’s place regularly to check whether you are using the inhalation device properly or not. Do not stop taking medicine or change the dose without discussing with you doctor. If you have any doubt about the usage instructions, please contact your doctor. For adults, the doctor usually asked to inhale the medication 2 to 4 times a day. Do not exceed the recommended dose of the asthma medication. The initial dose for elderly patients may be lower than the recommended dose of adults. If your condition gets worse, ask your doctor if you can use extra capsules. If you still do not get relief, visit your doctor straight away. Get immediate medical help if you become wheezy or feel tightness in the chest.
Side Effects of Serobid Rotacaps 50 mcg
There are possible side effects that may be associated with all constituting ingredients of this asthma medication. The side effects are possible with the use of Serobid Rotacaps but do not always occur. Also, some side effects may be severe and cause a life-threatening situation. Therefore, it is important to discuss with your doctor live you experience any adverse effect related to the drug. Some commonly reported side effects include muscle cramps, rash, feeling shaky, fast heart rate, palpitations, headache, inability to sleep low potassium levels in the blood, and nervousness. If you develop any other side effect which is not listed above, call your doctor for medical advice.
What is Serobid Rotacaps 50mcg used for?
Serobid Rotacaps 50mcg contains salmeterol xinafoate 50mcg — a long-acting beta-2 agonist (LABA) in a dry powder inhalation formulation for use with a Rotahaler device. Indications: maintenance treatment of asthma (as add-on to inhaled corticosteroids — never as monotherapy); prevention of exercise-induced bronchoconstriction; and maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. Salmeterol provides bronchodilation lasting 12 hours — enabling twice-daily dosing (morning and evening) for sustained airway patency. It works by activating beta-2 receptors on bronchial smooth muscle, causing relaxation and bronchodilation. CRITICAL: salmeterol is a long-acting bronchodilator and must never be used as a rescue medication — salbutamol (short-acting) is used for acute symptoms.
How should Serobid Rotacaps 50mcg be used with a Rotahaler?
Serobid Rotacaps are designed for use with a Rotahaler inhalation device. Usage: (1) insert the Rotacap capsule into the Rotahaler device; (2) rotate the device to pierce the capsule; (3) exhale completely, place the mouthpiece between teeth and lips making a seal; (4) inhale deeply and forcefully through the device — the powder is drawn into the lungs; (5) hold breath for 5–10 seconds, then exhale slowly; (6) check the capsule is empty (a rattling sound means powder remains — inhale again). Dose: one Rotacap (50mcg) twice daily — morning and evening (every 12 hours). Always use Serobid with an inhaled corticosteroid (ICS) for asthma — do not use as monotherapy. Clean the Rotahaler weekly by rinsing with warm water and allowing to dry completely before next use.
Why must Serobid Rotacaps never be used alone for asthma without an inhaled corticosteroid?
Salmeterol (LABA) monotherapy for asthma without inhaled corticosteroid (ICS) is contraindicated — based on the SMART trial which showed increased asthma-related deaths with salmeterol monotherapy vs. placebo. The mechanism: salmeterol provides bronchodilation (symptom control) but has no anti-inflammatory effect — the underlying airway inflammation that drives asthma continues unchecked and can worsen silently. Patients may perceive symptom control from bronchodilation while airway inflammation worsens — increasing risk of severe, potentially fatal exacerbations. Safe use: Serobid 50mcg must always be used alongside an ICS (e.g., a separate fluticasone or beclomethasone inhaler, or a fixed-dose ICS/LABA combination product). For patients who struggle with two separate inhalers: a fixed-dose ICS+LABA combination (Seroflo/Advair/Symbicort) eliminates the risk of using the LABA without ICS.
What drug interactions apply to Serobid Rotacaps 50mcg?
CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, erythromycin): increase salmeterol plasma levels significantly — particularly ketoconazole. The combination of ketoconazole and salmeterol can cause QT prolongation and cardiovascular effects — avoid concurrent use. Beta-blockers (atenolol, metoprolol, carvedilol): directly antagonise salmeterol's bronchodilatory effect — avoid in asthma; use with extreme caution in COPD (selective beta-1 blockers are preferred if essential). Diuretics (loop diuretics, thiazides) and corticosteroids: hypokalaemia risk with salmeterol — ECG and potassium monitoring advised with concurrent use. MAO inhibitors and tricyclic antidepressants: potentiate cardiovascular effects of beta-agonists — avoid within 14 days of MAO inhibitors. Other beta-2 agonists (including short-acting salbutamol at high doses): additive beta-2 effects — hypokalaemia and tachycardia risk.
Is Serobid 50mcg safe in pregnancy?
Salmeterol is FDA Category C in pregnancy — limited human data; animal studies at high doses show some teratogenicity. For pregnant women with asthma: well-controlled asthma is critical for fetal outcomes — uncontrolled asthma causes more harm than asthma medications. LABAs are used in pregnancy when ICS alone does not provide adequate asthma control. Evidence base: salmeterol has been used during pregnancy with no consistent evidence of adverse fetal outcomes in human studies. Current guidelines: ICS is the cornerstone of asthma control in pregnancy; add salmeterol (Serobid) as an add-on only when the ICS dose alone is insufficient — the benefit of asthma control outweighs the theoretical LABA risk. Discuss with your obstetrician and respiratory physician if LABA therapy is required during pregnancy.
Is Serobid 50mcg equivalent to Serevent 50mcg Accuhaler?
Yes. Serobid Rotacaps 50mcg and branded Serevent 50mcg Accuhaler (or Diskus) both deliver salmeterol xinafoate 50mcg per dose as dry powder inhalation. The device differs (Rotahaler vs. Accuhaler) but the active drug and dose are equivalent. Serobid is the generic alternative providing the same long-acting bronchodilator therapy at significantly lower cost. PremiumRxDrugs.com stocks authentic manufacturer-sourced Serobid Rotacaps verified for quality and bioequivalence.
Can I order Serobid Rotacaps from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Serobid Rotacaps 50mcg to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified LABA inhalation products, competitive pricing, and free worldwide shipping on qualifying orders make a reliable international pharmacy for salmeterol therapy.
What side effects does Serobid Rotacaps 50mcg cause?
Common: tremor (fine hand tremor from beta-2 skeletal muscle stimulation — usually mild and diminishing over weeks); palpitations (tachycardia — beta-2 receptors in the heart); headache. Hypokalaemia (low potassium): particularly at high doses or combined with diuretics/corticosteroids — monitor potassium in at-risk patients. Throat irritation and dry mouth (inhaled powder). Paradoxical bronchospasm (rare — immediate worsening after inhalation; discontinue immediately if this occurs and use short-acting bronchodilator). Cardiovascular: QT prolongation and arrhythmias with excessive doses or drug interactions (particularly with ketoconazole). Hyperglycaemia (mild blood glucose elevation — relevant in diabetics). Hypersensitivity reactions including anaphylaxis (very rare). The side effect profile is generally mild at standard twice-daily 50mcg dosing.
Can Serobid Rotacaps be used for COPD?
Salmeterol 50mcg twice daily is an approved and effective bronchodilator for COPD maintenance treatment. In COPD: salmeterol reduces dyspnoea (breathlessness), increases exercise tolerance, reduces exacerbation frequency, and improves quality of life. Unlike asthma, salmeterol LABA monotherapy is appropriate and commonly used in COPD (the ICS-monotherapy safety concern is specific to asthma, where underlying eosinophilic inflammation requires corticosteroid control). For moderate-severe COPD: ICS+LABA combination (Seroflo) is often used for patients with frequent exacerbations. LABA monotherapy (Serobid 50mcg) is appropriate for COPD patients with infrequent exacerbations, or in combination with a LAMA (long-acting muscarinic antagonist like tiotropium) for dual bronchodilation — a combination that provides superior COPD control compared to either LABA or LAMA alone.
What is the correct storage for Serobid Rotacaps?
Store Serobid Rotacaps at room temperature (below 30°C) away from direct sunlight, heat, and humidity. Keep in the original foil/blister packaging until immediately before use — the dry powder is moisture-sensitive (humidity causes clumping that prevents inhalation). Never wash or wet the interior of the Rotahaler device — clean the mouthpiece with a dry cloth only. Keep both the Rotacaps and the Rotahaler out of reach of children. Do not refrigerate — cold conditions increase humidity effects on the powder. Check expiry date before use. Carry the Rotacaps in a sealed pouch when travelling in humid environments. If the Rotacap rattles during use but powder is not inhaled: check device technique; moisture may have partially clumped the powder — use a fresh Rotacap if the current one does not empty fully.
When should a patient using Serobid contact their doctor urgently?
Seek immediate medical attention with Serobid 50mcg therapy if: increasing shortness of breath — particularly if requiring rescue salbutamol more than twice per week (indicates worsening asthma control — step up treatment needed); awakening at night due to breathlessness or wheeze (sign of poor asthma control); use of rescue salbutamol before each dose of Serobid (dependence on short-acting rescue means long-acting bronchodilator is insufficient); paradoxical bronchospasm immediately after Serobid inhalation (stop and use salbutamol); chest pain or rapid irregular heartbeat; severe tremor or muscle weakness (hypokalaemia); no improvement in COPD exacerbation with standard management. Annual spirometry review and asthma/COPD action plan review are recommended for all patients on LABA therapy.
Login
Sign Up
Login
Sign Up